Search Results - "Weiss, J. Peter"

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation by Jacobs, Victoria, NP, May, Heidi T., PhD, Bair, Tami L., RN, Crandall, Brian G., MD, Cutler, Michael J., DO, PhD, Day, John D., MD, Mallender, Charles, MD, Osborn, Jeffrey S., MD, Stevens, Scott M., MD, Weiss, J. Peter, MD, Woller, Scott C., MD, Bunch, T. Jared, MD

“…Direct oral anticoagulants (DOACs) have been used in clinical practice in the United States for the last 4 to 6 years. Although DOACs may be an attractive…”
Get full text

Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit by Nishimura, Takuro, Shatz, Nathan, Weiss, J. Peter, Zawaneh, Michael, Bai, Rong, Beaser, Andrew D., Upadhyay, Gaurav A., Aziz, Zaid A., Nayak, Hemal M., Shatz, Dalise Y., Miyazaki, Shinsuke, Goya, Masahiko, Sasano, Tetsuo, Su, Wilber, Raiman, Michael, Tung, Roderick

“…BACKGROUND: The circuit boundaries for reentrant ventricular tachycardia (VT) have been historically conceptualized within a 2-dimensional (2D) construct, with…”
Get full text

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score by Bunch, T. Jared, MD, May, Heidi T., PhD, MSPH, Bair, Tami L., BS, Weiss, J. Peter, MD, Crandall, Brian G., MD, Osborn, Jeffrey S., MD, Mallender, Charles, MD, Anderson, Jeffrey L., MD, Muhlestein, Brent J., MD, Lappe, Donald L., MD, Day, John D., MD, FHRS

“…Background Atrial fibrillation (AF) is a leading cause of total and fatal ischemic stroke. Stroke risk after AF ablation appears to be favorably affected;…”
Get full text

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia by Jacobs, Victoria, NP, Woller, Scott C., MD, Stevens, Scott, MD, May, Heidi T., PhD, Bair, Tami L., RN, Anderson, Jeffrey L., MD, Crandall, Brian G., MD, Day, John D., MD, FHRS, Johanning, Katie, PharmD, Long, Yenh, PharmD, Mallender, Charles, MD, Olson, Jeffrey L., PharmD, Osborn, Jeffrey S., MD, Weiss, J. Peter, MD, Bunch, T. Jared, MD

“…Background The mechanisms behind the association of atrial fibrillation (AF) and dementia are unknown. One possibility is that exposure to chronic…”
Get full text

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia by Bunch, T. Jared, MD, Weiss, J. Peter, MD, Crandall, Brian G., MD, May, Heidi T., PhD, MSPH, Bair, Tami L., RN, Osborn, Jeffrey S., MD, Anderson, Jeffrey L., MD, Muhlestein, Joseph B., MD, Horne, Benjamin D., PhD, MSPH, Lappe, Donald L., MD, Day, John D., MD, FHRS

“…Background The aging population has resulted in more patients living with cardiovascular disease, such as atrial fibrillation (AF). Recent focus has been…”
Get full text

The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation by BUNCH, T. JARED, MAY, HEIDI T., BAIR, TAMI L., JACOBS, VICTORIA, CRANDALL, BRIAN G., CUTLER, MICHAEL, WEISS, J. PETER, MALLENDER, CHARLES, OSBORN, JEFFREY S., ANDERSON, JEFFREY L., DAY, JOHN D.

“…Impact of Age After Atrial Fibrillation Catheter Ablation Background Catheter ablation of atrial fibrillation (AF) is an established therapeutic rhythm…”
Get full text

The impact of risk score (CHADS2 versus CHA2 DS2 -VASc ) on long-term outcomes after atrial fibrillation ablation by Jacobs, Victoria, NP, May, Heidi T., PhD, MSPH, Bair, Tami L., RN, Crandall, Brian G., MD, Cutler, Michael, DO, PhD, Day, John D., MD, FHRS, Weiss, J. Peter, MD, Osborn, Jeffrey S., MD, Muhlestein, Joseph B., MD, Anderson, Jeffrey L., MD, Mallender, Charles, MD, Bunch, T. Jared, MD

“…Background Risk stratification tools are needed to select the right candidates for catheter ablation of atrial fibrillation (AF). Both the CHADS2 and CHA2 DS2…”
Get full text

Ventricular Tachycardia Ablation in Severe Heart Failure: An International Ventricular Tachycardia Ablation Center Collaboration Analysis by Tzou, Wendy S, Tung, Roderick, Frankel, David S, Vaseghi, Marmar, Bunch, T Jared, Di Biase, Luigi, Tholakanahalli, Venkatakrishna N, Lakkireddy, Dhanunjaya, Dickfeld, Timm, Saliaris, Anastasios, Weiss, J Peter, Mathuria, Nilesh, Tedrow, Usha, Afzal, Mohammed R, Vergara, Pasquale, Nagashima, Koichi, Patel, Mehul, Nakahara, Shiro, Vakil, Kairav, Burkhardt, J David, Tseng, Chi-Hong, Natale, Andrea, Shivkumar, Kalyanam, Callans, David J, Stevenson, William G, Della Bella, Paolo, Marchlinski, Francis E, Sauer, William H

“…BACKGROUND—Ventricular tachycardia (VT) radiofrequency ablation has been associated with reduced VT recurrence and mortality, although it is typically not…”
Get full text

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes by Bunch, T. Jared, MD, May, Heidi T., PhD, Bair, Tami L., RN, Johnson, David L., PAC, Weiss, J. Peter, MD, Crandall, Brian G., MD, Osborn, Jeffrey S., MD, Anderson, Jeffrey L., MD, Muhlestein, J. Brent, MD, Lappe, Donald L., MD, Day, John D., MD, FHRS

“…Background Many patients who develop atrial fibrillation (AF) will experience a worsening of their arrhythmia over time. The optimal time to proceed with…”
Get full text

Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only by Jared Bunch, T., MD, Peter Weiss, J., MD, Crandall, Brian G., MD, Day, John D., MD, FHRS, May, Heidi T., PhD, MSPH, Bair, Tami L., RN, Osborn, Jeffrey S., MD, Mallender, Charles, MD, Fischer, Avi, MD, Brunner, Kyle J., MBA, Mahapatra, Srijoy, MD

“…Background Ventricular arrhythmias in patients with implantable cardioverter-defibrillators (ICDs) adversely affect outcomes. Antiarrhythmic approaches to…”
Get full text

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications by Bunch, T. Jared, May, Heidi T., Bair, Tami L., Crandall, Brian G., Cutler, Michael J., Day, John D., Jacobs, Victoria, Mallender, Charles, Osborn, Jeffrey S., Stevens, Scott M., Weiss, J. Peter, Woller, Scott C.

“…Background The mechanisms behind the association of atrial fibrillation (AF) and dementia are unknown. We previously found a significantly increased risk of…”
Get full text

Long-Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians by BUNCH, T. JARED, WEISS, J. PETER, CRANDALL, BRIAN G., MAY, HEIDI T., BAIR, TAMI L., OSBORN, JEFFREY S., ANDERSON, JEFFREY L., LAPPE, DONALD L., MUHLESTEIN, J. BRENT, NELSON, JENNIFER, DAY, JOHN D.

“…Background: Radiofrequency ablation is an effective treatment for atrial fibrillation (AF). With improved safety, the therapy has been offered to increasingly…”
Get full text

Best practices in robotic magnetic navigation-guided catheter ablation of cardiac arrhythmias, a position paper of the Society for Cardiac Robotic Navigation by Noten, Anna M E, Szili-Torok, Tamas, Ernst, Sabine, Burkhardt, David, Cavaco, Diogo, Chen, Xu, Cheung, Jim W, de Chillou, Christian, Crystal, Eugene, Cooper, Daniel H, Gasparini, Maurizio, Geczy, Tamas, Goehl, Konrad, Hügl, Burkhard, Jin, Qi, Kampus, Priit, Kazemian, Pedram, Khan, Muchtiar, Kongstad, Ole, Magga, Jarkko, Peress, Darren, Raatikainen, Pekka, Romanov, Alexander, Rossvoll, Ole, Singh, Gurjit, Vatasescu, Radu, Wijchers, Sip, Yamashiro, Kohei, Yap, Sing-Chien, Weiss, J Peter

“…Robotic magnetic navigation (RMN)-guided catheter ablation (CA) technology has been used for the treatment of cardiac arrhythmias for almost 20 years. Various…”
Get full text

Early Feasibility Studies in United States: Focus on Electrophysiology by Weiss, J Peter, Farb, Andrew

“…The care of patients with heart rhythm disorders is often dependent on technologies developed to address their unique clinical needs. Although much innovation…”
Get full text

The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation by Golive, Anjani, MD, May, Heidi T., PhD, Bair, Tami L, Jacobs, Victoria, PhD, Crandall, Brian G., MD, Cutler, Michael J., DO, PhD, Day, John D., MD, Mallender, Charles, MD, Osborn, Jeffrey S., MD, Stevens, Scott M., MD, Weiss, J. Peter, MD, Woller, Scott C., MD, Bunch, T. Jared, MD

“…Abstract Among patients with atrial fibrillation (AF), the risk of stroke risk is a significant concern. CHADS2 and CHA2 DS2 -VASc ≤2 scoring have been used to…”
Get full text

Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation by Bunch, T. Jared, May, Heidi T., Bair, Tami L., Crandall, Brian G., Cutler, Michael J, Jacobs, Victoria, Mallender, Charles, Muhlestein, Joseph B., Osborn, Jeffrey S., Weiss, J. Peter, Day, John D.

“…Background Catheter ablation of atrial fibrillation (AF) is an established therapeutic rhythm approach in symptomatic patients. Obesity is a dominant driver of…”
Get full text

Telemedicine in cardiac procedures: considerations for a remote future by Weiss, J. Peter

“…PURPOSE OF REVIEWPresent a review of relevant literature and suggest a framework for discussion of the considerations affecting the evolution and adoption of…”
Get full text

Freedom from electromagnetic interference between cardiac implantable electronic devices and the FMwand ferromagnetic surgical system by Weiss, J. Peter, MD, MSc, Manwaring, Preston, MSEE

“…[...]the energy circuit is a closed loop, eliminating the need for a remote grounding electrode (Fig. 1). [...]the system is able to simultaneously cut and…”
Get full text

Robotics, remote medicine, AI: Oh my by Weiss, J Peter

Get full text

Relation of Bisphosphonate Therapies and Risk of Developing Atrial Fibrillation by Bunch, T. Jared, MD, Anderson, Jeffrey L., MD, May, Heidi T., MSPH, Muhlestein, Joseph B., MD, Horne, Benjamin D., PhD, MPH, Crandall, Brian G., MD, Weiss, J. Peter, MD, Lappé, Donald L., MD, Osborn, Jeffrey S., MD, Day, John D., MD

“…Bisphosphonates comprise the most common treatment for patients with osteoporosis and fracture risk. Large randomized trials have shown that these therapies…”
Get full text